Skip to main content

Table 2 Function and bother scores (mean ± standard deviation; median) in dependence on age group

From: Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment

 

≤65 years

66-70 years

71-75 years

>75 years

urinary function

94 ± 13; 100

92 ± 15; 100

91 ± 14; 100

92 ± 12; 94

continence function*

92 ± 18; 100

88 ± 21; 100

85 ± 23; 100

87 ± 20; 94

irritative/obstructive function

95 ± 13; 100

97 ± 12; 100

98 ± 10; 100

98 ± 9; 94

urinary bother†

82 ± 20; 89

84 ± 20; 91

82 ± 18; 89

79 ± 19; 86

continence bother

93 ± 22; 100

90 ± 25; 100

90 ± 25; 100

90 ± 22; 100

irritative/obstructive bother

80 ± 20; 90

83 ± 20; 90

81 ± 18; 85

79 ± 18; 83

bowel function

91 ± 11; 96

93 ± 9; 96

93 ± 9; 96

93 ± 9; 96

bowel bother

93 ± 14; 100

93 ± 14; 100

95 ± 10; 100

93 ± 13; 100

sexual function‡

48 ± 25; 50

43 ± 23; 50

35 ± 23; 32

30 ± 24; 28

sexual bother

68 ± 32; 75

64 ± 34; 75

56 ± 36; 56

60 ± 33; 63

hormonal function §

88 ± 17; 100

91 ± 16; 100

92 ± 13; 100

95 ± 10; 100

hormonal bother

89 ± 16; 96

91 ± 15; 100

92 ± 14; 96

94 ± 11; 100

  1. *significant difference ≤65 vs. 71-75/>75 years (p < 0.01)
  2. † significant difference 66-70 vs. >75 years (p < 0.01)
  3. ‡ significant difference ≤65 vs. 71-75/>75 and 66-70 vs. 71-75/>75 years (p < 0.01)
  4. § significant difference ≤65 vs. >75 years (p = 0.03)